Eun Mi Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eun Mi Yang has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Chan Jong Kim
Department of Pediatrics, Chonnam National University Medical School and Children’s Hospital, Gwangju, Korea
14 shared publications - Hee Gyung Kang
Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea
10 shared publications - Yo Han Ahn
Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea
10 shared publications - Eujin Park
Department of Pediatrics, Korea University Guro Hospital, Seoul, Republic of Korea
8 shared publications - Kyoung Hee Han
Department of Pediatrics, Jeju National University College of Medicine and Graduate School of Medicine, Jeju, Republic of Korea
8 shared publications - Min Hyun Cho
Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
7 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by Korean Society of Pediatric Nephrology in Childhood Kidney Diseases
- Vol. 30 (3) , 198-208
Target antigens and antigen-specific clinical phenotypes in pediatric membranous nephropathy
Purpose: Primary membranous nephropathy (MN) is rare in childhood and increasingly understood as a spectrum of antigen- defined diseases. The distribution of glomerular target antigens and their clinical relevance in pediatric MN remain poorly defined.Methods: We systematically reviewed English-language reports of biopsy-confirmed MN diagnosed at ≤18 years of age. Databases were searched through August 1, 2026. Tissue-antigen and serum-antibody evidence were analyzed separately, overlapping cohorts were audited, and tissue M-type phospholipase A2 receptor (PLA2R) prevalence was pooled with a binomial-normal random- effects generalized linear mixed model.Results: Twenty-three reports were included. Ten independent tissue cohorts comprised 196 patients; 74 were PLA2R-positive (crude proportion, 37.8%). Pooled tissue PLA2R prevalence was 38.5% (95% confidence interval, 25.7%–53.2%; 95% prediction interval, 8.2%–81.5%; model-based I2=70.1%). Several cohorts suggested greater PLA2R positivity in older children. Exostosin 1 and 2 were linked to autoimmune or lupus-like features. All seven neural epidermal growth factor-like 1–positive patients were female and associated with environmental exposure. Semaphorin 3B positivity suggested early-childhood onset and male predominance.Conclusions: Current evidence is insufficient to use antigen status alone for prognostic or treatment stratification in pediatric MN. Nevertheless, antigen typing may refine diagnosis and etiologic evaluation by prompting assessment for autoimmunity or relevant exposures. Serial anti-PLA2R measurement may support patient monitoring although tissue and serum findings are not interchangeable.
- 16 October 2026
- Published by Korean Society of Pediatric Nephrology in Childhood Kidney Diseases
- Vol. 30 (3) , 198-208
Open AccessTarget antigens and antigen-specific clinical phenotypes in pediatric membranous nephropathy
Purpose: Primary membranous nephropathy (MN) is rare in childhood and increasingly understood as a spectrum of antigen- defined diseases. The distribution of glomerular target antigens and their clinical relevance in pediatric MN remain poorly defined.Methods: We systematically reviewed English-language reports of biopsy-confirmed MN diagnosed at ≤18 years of age. Databases were searched through August 1, 2026. Tissue-antigen and serum-antibody evidence were analyzed separately, overlapping cohorts were audited, and tissue M-type phospholipase A2 receptor (PLA2R) prevalence was pooled with a binomial-normal random- effects generalized linear mixed model.Results: Twenty-three reports were included. Ten independent tissue cohorts comprised 196 patients; 74 were PLA2R-positive (crude proportion, 37.8%). Pooled tissue PLA2R prevalence was 38.5% (95% confidence interval, 25.7%–53.2%; 95% prediction interval, 8.2%–81.5%; model-based I2=70.1%). Several cohorts suggested greater PLA2R positivity in older children. Exostosin 1 and 2 were linked to autoimmune or lupus-like features. All seven neural epidermal growth factor-like 1–positive patients were female and associated with environmental exposure. Semaphorin 3B positivity suggested early-childhood onset and male predominance.Conclusions: Current evidence is insufficient to use antigen status alone for prognostic or treatment stratification in pediatric MN. Nevertheless, antigen typing may refine diagnosis and etiologic evaluation by prompting assessment for autoimmunity or relevant exposures. Serial anti-PLA2R measurement may support patient monitoring although tissue and serum findings are not interchangeable.
- Open Access
- 3 July 2026
- Published by Springer Nature in Research Square
Effect of Puberty on Kidney Function in children with chronic kidney disease
Background Puberty is characterized by major physiologic changes as children mature into young adults and is widely considered a critical phase for kidney function deterioration in children with chronic kidney disease (CKD). However, studies examining the effect of puberty on CKD progression remain limited. Methods We analyzed a multicenter prospective cohort of 212 children with CKD. Longitudinal trajectories of estimated glomerular filtration rate (eGFR) before and after puberty were evaluated using peak height velocity (PHV) as an objective growth-based reference point. Changes in creatinine-based eGFR (eGFRcr) and creatinine–cystatin C–based eGFR (eGFRcr-cys) from baseline through puberty to the last follow-up were assessed. Subgroup analyses were performed according to baseline CKD stage. Results Of the 212 children analyzed (156 males, 56 females), the mean age at PHV was 15.2 ± 3.3 years. A significant, non-linear decline in eGFR was observed across the pubertal transition. Both eGFRcr and eGFRcr-cys declined from baseline to PHV, followed by accelerated decline after PHV. This significant and rapid post-PHV decline in eGFR was consistently observed in both sexes. Children with CKD stages 1–4 showed substantial declines in eGFR during puberty, although the reduction were more pronounced in children with CKD stage 1. Conclusions Puberty was associated with a significant eGFR decline in children with CKD, including those with early-stage disease. The consistent decline observed in both eGFRcr and eGFRcr-cys suggests that the decline is not solely explained by pubertal changes in muscle mass. These findings highlight the need for vigilant monitoring during pubertal transition, even in children with preserved baseline kidney function.
- 3 July 2026
- Published by Springer Nature in Research Square
Open AccessEffect of Puberty on Kidney Function in children with chronic kidney disease
Background Puberty is characterized by major physiologic changes as children mature into young adults and is widely considered a critical phase for kidney function deterioration in children with chronic kidney disease (CKD). However, studies examining the effect of puberty on CKD progression remain limited. Methods We analyzed a multicenter prospective cohort of 212 children with CKD. Longitudinal trajectories of estimated glomerular filtration rate (eGFR) before and after puberty were evaluated using peak height velocity (PHV) as an objective growth-based reference point. Changes in creatinine-based eGFR (eGFRcr) and creatinine–cystatin C–based eGFR (eGFRcr-cys) from baseline through puberty to the last follow-up were assessed. Subgroup analyses were performed according to baseline CKD stage. Results Of the 212 children analyzed (156 males, 56 females), the mean age at PHV was 15.2 ± 3.3 years. A significant, non-linear decline in eGFR was observed across the pubertal transition. Both eGFRcr and eGFRcr-cys declined from baseline to PHV, followed by accelerated decline after PHV. This significant and rapid post-PHV decline in eGFR was consistently observed in both sexes. Children with CKD stages 1–4 showed substantial declines in eGFR during puberty, although the reduction were more pronounced in children with CKD stage 1. Conclusions Puberty was associated with a significant eGFR decline in children with CKD, including those with early-stage disease. The consistent decline observed in both eGFRcr and eGFRcr-cys suggests that the decline is not solely explained by pubertal changes in muscle mass. These findings highlight the need for vigilant monitoring during pubertal transition, even in children with preserved baseline kidney function.
- Open Access
- 18 April 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-11
Clinical characteristics and genetic analyses of Korean children with Dent disease
Background Dent disease is a hereditary kidney tubular disorder caused by pathogenic variants in either the CLCN5 (Dent disease 1) or OCRL1 (Dent disease 2) genes. As a rare genetic disorder, Dent disease often presents with variable clinical manifestations, leading to frequent misdiagnosis or underdiagnosis, especially in milder cases. Consequently, limited research has addressed the long-term clinical outcomes of Dent disease. Methods This retrospective multicenter cohort study was conducted at 9 hospitals in Korea. A total of 48 male patients from 44 unrelated families with genetically confirmed Dent disease were enrolled, and their clinical phenotypes, and genetic backgrounds were assessed. Result The median age at diagnosis for Dent disease was 6.8 years, and 42 patients were diagnosed with Dent disease 1. At diagnosis, 17 patients (37.0%) demonstrated the classic triad of Dent disease features, whereas 12 patients (26.1%) presented solely with isolated low-molecular-weight proteinuria. During follow-up, whereas all patients maintained low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, and nephrolithiasis occurred in 82.6%, 56.5%, and 8.3% of patients, respectively. The cases with Dent disease 2 had a higher rate of hypophosphatemia and significant proteinuria compared to Dent disease 1. A negative correlation was identified between hypercalciuria and age in the overall Dent disease cohort. The decline rate of annual estimated glomerular filtration rate was 0.6 mL/min/1.73 m2, without the case of kidney failure. At last follow-up, kidney dysfunction was present in 39.5% of cases. Conclusions Due to its rarity and phenotype variability, Dent disease is frequently under-recognized by clinicians. As over one-third of patients progress to chronic kidney disease by early adulthood, a high index of clinical suspicion and early genetic testing are essential, alongside rigorous monitoring of kidney function. Graphical abstract The alternative text for this image may have been generated using AI. A higher resolution version of the Graphical abstract is available as Supplementary information
- 18 April 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-11
Open AccessClinical characteristics and genetic analyses of Korean children with Dent disease
Background Dent disease is a hereditary kidney tubular disorder caused by pathogenic variants in either the CLCN5 (Dent disease 1) or OCRL1 (Dent disease 2) genes. As a rare genetic disorder, Dent disease often presents with variable clinical manifestations, leading to frequent misdiagnosis or underdiagnosis, especially in milder cases. Consequently, limited research has addressed the long-term clinical outcomes of Dent disease. Methods This retrospective multicenter cohort study was conducted at 9 hospitals in Korea. A total of 48 male patients from 44 unrelated families with genetically confirmed Dent disease were enrolled, and their clinical phenotypes, and genetic backgrounds were assessed. Result The median age at diagnosis for Dent disease was 6.8 years, and 42 patients were diagnosed with Dent disease 1. At diagnosis, 17 patients (37.0%) demonstrated the classic triad of Dent disease features, whereas 12 patients (26.1%) presented solely with isolated low-molecular-weight proteinuria. During follow-up, whereas all patients maintained low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, and nephrolithiasis occurred in 82.6%, 56.5%, and 8.3% of patients, respectively. The cases with Dent disease 2 had a higher rate of hypophosphatemia and significant proteinuria compared to Dent disease 1. A negative correlation was identified between hypercalciuria and age in the overall Dent disease cohort. The decline rate of annual estimated glomerular filtration rate was 0.6 mL/min/1.73 m2, without the case of kidney failure. At last follow-up, kidney dysfunction was present in 39.5% of cases. Conclusions Due to its rarity and phenotype variability, Dent disease is frequently under-recognized by clinicians. As over one-third of patients progress to chronic kidney disease by early adulthood, a high index of clinical suspicion and early genetic testing are essential, alongside rigorous monitoring of kidney function. Graphical abstract The alternative text for this image may have been generated using AI. A higher resolution version of the Graphical abstract is available as Supplementary information
- Open Access
- 15 April 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14
Correction: Acute cyclosporine overdose in a child with nephrotic syndrome: a case report and literature review
- 15 April 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14
Open AccessCorrection: Acute cyclosporine overdose in a child with nephrotic syndrome: a case report and literature review
- 15 April 2026
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (10) , 3661
Response to Letter to the Editors “Factors influencing serum uric acid levels and their impact on cardiovascular risk in pediatric chronic kidney disease”
- 15 April 2026
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (10) , 3661
Response to Letter to the Editors “Factors influencing serum uric acid levels and their impact on cardiovascular risk in pediatric chronic kidney disease”
- Open Access
- 26 February 2026
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 30 (5) , 726-736
Association of anthropometric and biochemical–anthropometric obesity indices with chronic kidney disease in diabetes: a KNHANES-based study
Background: Obesity is a known risk factor for diabetes mellitus (DM) and chronic kidney disease (CKD), yet the relationship between various obesity-related indices and CKD remains unclear. This study evaluated the associations between eight obesity indices with CKD and identified the most useful index among patients with DM. Methods: This study used data from the Korean National Health and Nutrition Examination Survey conducted from 2007 to 2018. A total of 5,067 participants aged ≥ 20 years with DM were included. The study evaluated four traditional anthropometric obesity indices (body mass index [BMI], waist-to-height ratio [WHtR], body roundness index [BRI], conicity index [CI]) and four biochemical-anthropometric indices, including two Asian-specific indices (lipid accumulation product [LAP], visceral adiposity index [VAI], Chinese visceral adiposity index [CVAI], and new visceral adiposity index [NVAI]). Results: WHtR, BRI, CI, CVAI, and NVAI were higher in males with CKD, while only CI, CVAI, and NVAI were elevated in females. All eight indices were independently associated with CKD risk in males, whereas only the anthropometric-biochemical indices LAP, VAI, and CVAI were significantly associated with CKD in females. NVAI in males and CVAI in females exhibited the highest area under the curve values of 0.615 and 0.658, respectively. Conclusions: Various obesity indices were associated with CKD in patients with DM, although the associations differed by sex. Asian-specific indices may be the most useful for reflecting CKD in patients with DM.
- 26 February 2026
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 30 (5) , 726-736
Open AccessAssociation of anthropometric and biochemical–anthropometric obesity indices with chronic kidney disease in diabetes: a KNHANES-based study
Background: Obesity is a known risk factor for diabetes mellitus (DM) and chronic kidney disease (CKD), yet the relationship between various obesity-related indices and CKD remains unclear. This study evaluated the associations between eight obesity indices with CKD and identified the most useful index among patients with DM. Methods: This study used data from the Korean National Health and Nutrition Examination Survey conducted from 2007 to 2018. A total of 5,067 participants aged ≥ 20 years with DM were included. The study evaluated four traditional anthropometric obesity indices (body mass index [BMI], waist-to-height ratio [WHtR], body roundness index [BRI], conicity index [CI]) and four biochemical-anthropometric indices, including two Asian-specific indices (lipid accumulation product [LAP], visceral adiposity index [VAI], Chinese visceral adiposity index [CVAI], and new visceral adiposity index [NVAI]). Results: WHtR, BRI, CI, CVAI, and NVAI were higher in males with CKD, while only CI, CVAI, and NVAI were elevated in females. All eight indices were independently associated with CKD risk in males, whereas only the anthropometric-biochemical indices LAP, VAI, and CVAI were significantly associated with CKD in females. NVAI in males and CVAI in females exhibited the highest area under the curve values of 0.615 and 0.658, respectively. Conclusions: Various obesity indices were associated with CKD in patients with DM, although the associations differed by sex. Asian-specific indices may be the most useful for reflecting CKD in patients with DM.
- Open Access
- 22 January 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1737399
Acute cyclosporine overdose in a child with nephrotic syndrome: a case report and literature review
Background: Calcineurin inhibitors are widely used in organ transplantation and nephrotic syndrome, with chronic toxicities well documented, but acute toxicity is rarely reported. Case presentation: We report a 3.9-year-old boy with steroid-dependent nephrotic syndrome who accidentally ingested a single dose of cyclosporine A (CsA) at 75 mg/kg (1,500 mg)— over 20 times the intended dose of 3.5 mg/kg (70 mg)—due to medication error. He developed transient abdominal pain, diarrhea, and vomiting, which resolved without treatment. Error was discovered 12 h post-ingestion, and he was hospitalized with a CsA trough level of 1003 ng/mL (measured 13 h after ingestion), yet remained clinically stable. Management included CsA discontinuation, intravenous hydration, rifampin- and phenobarbital-induced cytochrome P450 activation, resulting in normalization of CsA levels within 48 h. A literature review identified 28 pediatric cases of acute CsA overdose, with presentations ranging from asymptomatic to severe neurotoxicity and acute kidney injury. The varied, including supportive care, gastrointestinal decontamination, and enzyme induction, with generally favorable outcomes. Conclusions: Although rare, acute CsA overdose in children can pose serious risks. This case and review underscore the symptoms of overdose and prompt intervention to prevent complications.
- 22 January 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1737399
Open AccessAcute cyclosporine overdose in a child with nephrotic syndrome: a case report and literature review
Background: Calcineurin inhibitors are widely used in organ transplantation and nephrotic syndrome, with chronic toxicities well documented, but acute toxicity is rarely reported. Case presentation: We report a 3.9-year-old boy with steroid-dependent nephrotic syndrome who accidentally ingested a single dose of cyclosporine A (CsA) at 75 mg/kg (1,500 mg)— over 20 times the intended dose of 3.5 mg/kg (70 mg)—due to medication error. He developed transient abdominal pain, diarrhea, and vomiting, which resolved without treatment. Error was discovered 12 h post-ingestion, and he was hospitalized with a CsA trough level of 1003 ng/mL (measured 13 h after ingestion), yet remained clinically stable. Management included CsA discontinuation, intravenous hydration, rifampin- and phenobarbital-induced cytochrome P450 activation, resulting in normalization of CsA levels within 48 h. A literature review identified 28 pediatric cases of acute CsA overdose, with presentations ranging from asymptomatic to severe neurotoxicity and acute kidney injury. The varied, including supportive care, gastrointestinal decontamination, and enzyme induction, with generally favorable outcomes. Conclusions: Although rare, acute CsA overdose in children can pose serious risks. This case and review underscore the symptoms of overdose and prompt intervention to prevent complications.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (50)
Epidemiology and Disparities in Kidney Replacement Therapy Among Children and Young Adults: A Nationwide Cohort Study in Korea
Yang EM, et al. J Korean Med Sci. 2026 Dec;41:e324. https://doi.org/10.3346/jkms.2026.41.e324
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (50)
Open AccessEpidemiology and Disparities in Kidney Replacement Therapy Among Children and Young Adults: A Nationwide Cohort Study in Korea
Yang EM, et al. J Korean Med Sci. 2026 Dec;41:e324. https://doi.org/10.3346/jkms.2026.41.e324
- 14 October 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (2) , 529-538
Factors influencing serum uric acid levels and their impact on cardiovascular risk in patients with pediatric chronic kidney disease
Background Elevated serum uric acid levels are commonly observed in chronic kidney disease (CKD) and are associated with cardiovascular disease (CVD). Research on the role of serum uric acid in pediatric CKD is limited. This study aims to investigate factors influencing serum uric acid levels and their association with CVD risk factors in children with CKD. Methods We used baseline data from the KoreaN cohort study for Outcome in patients with Pediatric Chronic Kidney Disease. Overall, 338 children with CKD were included. Results The median age of participants was 9.8 years, and their mean estimated glomerular filtration rate (eGFR) was 63.5 mL/min/1.73 m2. The median serum uric acid level was 5.8 mg/dL. Multivariable regression analysis indicated that male sex, older age, and low eGFR were associated with higher serum uric acid levels. In children with CKD stage III or higher, glomerulopathy as the etiology of CKD was also associated with elevated serum uric acid levels. Serum uric acid levels showed a U-shaped relationship with the prevalence of hypertension and left ventricular hypertrophy, with the lowest prevalence occurring at levels between 5.5 and 7.5 mg/dL, even after adjustment for covariates, with the lowest odds ratio in this range. Conclusions In pediatric CKD, higher serum uric acid levels were associated with male sex, older age, and lower eGFR, suggesting that these factors should be considered in clinical management. Additionally, the U-shaped relationship between serum uric acid levels and cardiovascular risk of hypertension and left ventricular hypertrophy underscores the importance of maintaining serum uric acid within an optimal range. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 14 October 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (2) , 529-538
Factors influencing serum uric acid levels and their impact on cardiovascular risk in patients with pediatric chronic kidney disease
Background Elevated serum uric acid levels are commonly observed in chronic kidney disease (CKD) and are associated with cardiovascular disease (CVD). Research on the role of serum uric acid in pediatric CKD is limited. This study aims to investigate factors influencing serum uric acid levels and their association with CVD risk factors in children with CKD. Methods We used baseline data from the KoreaN cohort study for Outcome in patients with Pediatric Chronic Kidney Disease. Overall, 338 children with CKD were included. Results The median age of participants was 9.8 years, and their mean estimated glomerular filtration rate (eGFR) was 63.5 mL/min/1.73 m2. The median serum uric acid level was 5.8 mg/dL. Multivariable regression analysis indicated that male sex, older age, and low eGFR were associated with higher serum uric acid levels. In children with CKD stage III or higher, glomerulopathy as the etiology of CKD was also associated with elevated serum uric acid levels. Serum uric acid levels showed a U-shaped relationship with the prevalence of hypertension and left ventricular hypertrophy, with the lowest prevalence occurring at levels between 5.5 and 7.5 mg/dL, even after adjustment for covariates, with the lowest odds ratio in this range. Conclusions In pediatric CKD, higher serum uric acid levels were associated with male sex, older age, and lower eGFR, suggesting that these factors should be considered in clinical management. Additionally, the U-shaped relationship between serum uric acid levels and cardiovascular risk of hypertension and left ventricular hypertrophy underscores the importance of maintaining serum uric acid within an optimal range. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- Open Access
- 1 October 2025
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 18 (11)
Clinical outcomes among children with primary nephrogenic diabetes insipidus
Background: Primary nephrogenic diabetes insipidus (NDI) is a rare inherited disorder with limited data on long-term outcomes. This study assessed longitudinal outcomes with primary NDI. Methods: This multicenter retrospective study included 63 patients with primary NDI. Growth rates and estimated glomerular filtration (eGFR) were analyzed via a piecewise linear mixed-effects model during the pediatric period. Results: AVPR2 and AQP2 mutations were identified in 74.6% and 9.5% of patients, respectively. The median ages at diagnosis and last follow up were 0.41 and 12.37 years, respectively. Height Z-scores declined from birth to 1.5 years and improved thereafter, with slopes of −2.626, −0.563, 0.102, and 0.031 per year across breakpoints at 0.5, 1.5, and 7 years. Although none of the patients met the criteria for short stature by age 18, the mean final height Z-score remained below average and was significantly lower than that at birth. Weight and weight-for-height Z-scores initially declined and then improved, with slope changes at 0.5 and 0.7 years. By the age of 18, 38.9% were overweight or obese. eGFR increased rapidly before 1.4 years (slope 25.61 ml/min/1.73 m2/year), and slowly thereafter (slope 0.58), reaching eGFR ≥90 ml/min/1.73 m2 at a median age of 5.1 years. The proportion of patients with eGFR <90 ml/min/1.73 m2 decreased to 34.6% at 14 years, then rose to 43.8% by the age of 18. Treatment-associated complications included hypokalemia (64.5%), alkalosis (61.1%), and hyperuricemia (60.7%). Conclusions: Patients with primary NDI exhibit a dynamic growth trajectory, delayed achievement of normal GFR with subsequent risk of chronic kidney disease, and frequent treatment-associated complications. These findings underscore the need for timely and individualized long-term management.
- 1 October 2025
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 18 (11)
Open AccessClinical outcomes among children with primary nephrogenic diabetes insipidus
Background: Primary nephrogenic diabetes insipidus (NDI) is a rare inherited disorder with limited data on long-term outcomes. This study assessed longitudinal outcomes with primary NDI. Methods: This multicenter retrospective study included 63 patients with primary NDI. Growth rates and estimated glomerular filtration (eGFR) were analyzed via a piecewise linear mixed-effects model during the pediatric period. Results: AVPR2 and AQP2 mutations were identified in 74.6% and 9.5% of patients, respectively. The median ages at diagnosis and last follow up were 0.41 and 12.37 years, respectively. Height Z-scores declined from birth to 1.5 years and improved thereafter, with slopes of −2.626, −0.563, 0.102, and 0.031 per year across breakpoints at 0.5, 1.5, and 7 years. Although none of the patients met the criteria for short stature by age 18, the mean final height Z-score remained below average and was significantly lower than that at birth. Weight and weight-for-height Z-scores initially declined and then improved, with slope changes at 0.5 and 0.7 years. By the age of 18, 38.9% were overweight or obese. eGFR increased rapidly before 1.4 years (slope 25.61 ml/min/1.73 m2/year), and slowly thereafter (slope 0.58), reaching eGFR ≥90 ml/min/1.73 m2 at a median age of 5.1 years. The proportion of patients with eGFR <90 ml/min/1.73 m2 decreased to 34.6% at 14 years, then rose to 43.8% by the age of 18. Treatment-associated complications included hypokalemia (64.5%), alkalosis (61.1%), and hyperuricemia (60.7%). Conclusions: Patients with primary NDI exhibit a dynamic growth trajectory, delayed achievement of normal GFR with subsequent risk of chronic kidney disease, and frequent treatment-associated complications. These findings underscore the need for timely and individualized long-term management.